|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1725 I Street NW, Suite 900 |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 26422-24
|
||||||||
|
6. House ID# 302590000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Steven J Kravitz |
Date | 10/19/2022 8:27:21 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Federal courts and judicial nominees;
Nomination of Julie Rikelman to the U.S. Court of Appeals for the First Circuit;
Nomination of Bradley Garcia to the U.S. Court of Appeals for the D.C. Circuit;
Support for the continued confirmation of judges committed to civil and human rights;
H.R. 7647, the Supreme Court Ethics, Recusal and Transparency Act of 2022, regarding judicial ethics reform for the U.S. Supreme Court;
Expected nomination of Chad Meredith to a federal court situated in Kentucky.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, White House Office, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stephanie |
Yost |
|
|
|
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Reproductive healthcare in federal spending bills and the presidential budget;
FY23 appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies;
FY23 appropriations for Departments of Commerce and Justice, Science, and Related Agencies;
FY23 appropriations for Financial Services and General Government;
FY23 appropriations for Department of Homeland Security;
FY23 appropriations for Department of Defense;
FY23 appropriations for Departments of Labor, Health and Human Services, and Education, and related agencies;
FY23 appropriations for Department of State, Foreign Operations, and Related Programs;
H.R. 5376, budget reconciliation bill, regarding restrictions on access to maternal health programs;
Funding for global LGBTQI+ rights programs.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stephanie |
Yost |
|
|
|
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Restrictions on the use of U.S. foreign aid for abortion care and expansion to global health contracts;
Nomination of Geeta Rao Gupta to serve as Ambassador-At-Large for Global Womens Issues at the Department of State;
H.R. 556 and S. 142, Global Health, Empowerment and Rights Act, regarding foreign aid for healthcare organizations;
H.R. 3576 and S. 1864, Reproductive Rights Are Human Rights Act of 2021, regarding State Department reporting on reproductive rights;
H.R. 3938, Support UNFPA Funding Act, regarding funding for international family planning;
H.R. 1670 and S. 4641, Abortion is Health Care Everywhere Act, regarding foreign aid for health care organizations;
U.S. compliance with international treaties and legal obligations following the decision in Dobbs v. Jackson Womens Health Organization.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stephanie |
Yost |
|
|
|
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Reproductive Rights and Roe v. Wade;
State abortion bans and abortion access in the United States;
Administrative actions to protect and expand abortion access;
Administrative action to declare a national and public health emergency over Americans access to reproductive care following Dobbs v. Jackson Women Health Organization;
Access to abortion care for workers;
Access to information and resources for people seeking abortion care and reproductive health services;
Access to abortion, contraception, and maternity care for veterans, servicemembers, and dependents;
H.R. 8916, the Access to Reproductive Care for Servicemembers Act, regarding leave policies for servicemembers to seek abortion care;
Interim final rule on veterans access to reproductive health services;
H.R. 7900, FY23 National Defense Authorization Act;
Access to the contraceptive coverage benefit under the Affordable Care Act;
Access to contraceptives and reproductive health care without cost-sharing for TRICARE enrollees;
Title X family planning program;
H.R. 8424 and S. 4550, Expanding Access to Family Planning Act,
Access to over-the-counter contraception;
Trump administration refusal of care rule;
Denials of and nondiscrimination in healthcare;
Rescission of the refusal of care rule;
Rules implementing Section 1557 of the Affordable Care Act;
Treatment of pregnant incarcerated people and detainees;
Maternal health outcomes and care options;
Paid family and medical leave;
LGBTQ+ rights;
H.Res. 1209, recognizing that it is the duty of the Federal Government to develop and implement a Transgender Bill of Rights;
H.R. 804 and S. 248, FAMILY Act, regarding paid family leave;
H.R. 1065 and S. 1486, the Pregnant Workers Fairness Act, regarding discrimination against pregnant workers;
H.R. 5 and S. 393, the Equality Act, regarding ending discrimination for LGBTQIA+ individuals;
H.R. 2234 and S. 1021, the EACH Act of 2021, regarding access to affordable health insurance plans that cover abortion;
H.R. 3755, H.R. 8296, S.4132, and S. 1975, the Women's Health Protection Act, regarding access to abortion care;
S. 3713, the Reproductive Choice Act, regarding limited access to abortion care;
H.R. 8297, the Ensuring Womens Right to Reproductive Freedom Act, regarding the right to travel to access reproductive healthcare;
H.R. 8452, the Reproductive Health Travel Fund Act of 2022, regarding financial support for people traveling to access abortion care;
H.R. 8373 and S.4557, the Right to Contraception Act, regarding the an individuals right to use and provide contraceptives and related counseling;
H.R. 8650 and S. 4723, the Let Doctors Provide Reproductive Health Care Act, regarding protections for healthcare providers;
H.Con.Res. 109, Concurrent Resolution, regarding support for the recognition of September 26, 2022, as World Contraception Day and expressing the sense of the House of Representatives regarding global and domestic access to contraception;
H.R. 9040 and S.4764, the Reproductive Health Care Accessibility Act, regarding expanding access to reproductive health care for people with disabilities;
S. 4688, the Reproductive Freedom for All Act, regarding reproductive health decisions;
S. 4840, the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act, regarding restricting access to abortion;
Access to evidence-based medication abortion care;
H.Res. 1434, regarding access to reproductive health care by reaffirming the Food and Drug Administrations (FDA) authority to preempt state law and ensure access to reproductive health care products;
Criminalization of pregnancy outcomes or essential healthcare services;
H.Con.Res. 89, Concurrent Resolution, regarding the criminalization of essential health care, including the full range of sexual and reproductive health care such as abortion;
Healthcare data privacy;
H.R. 8111, My Body, My Data Act of 2022, regarding data privacy;
Moderation of abortion mis-and disinformation by social media companies;
Free choice of provider in Medicaid programs;
Violence against women;
S. 3623 and H.R. 1620, Violence Against Women Reauthorization Act of 2022.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Office of the Vice President of the United States
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stephanie |
Yost |
|
|
|
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
Voting Rights
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Stephanie |
Yost |
|
|
|
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Ceasing migrant expulsion under Title 42 and rejecting any legislative continuation of Title 42;
Opposing the use of abortion care-related arrests or convictions as a basis for any immigration enforcement action;
Ensuring right to travel to seek abortion care regardless of peoples immigration status;
Ensuring access to abortion care for people in immigration detention facilities.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Stephanie |
Yost |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |